Ottawa Allergy Research Corp
Ottawa, Ontario, Canada
Research institute in Ottawa, Ontario
1081 Carling Ave Suit 800, Ottawa, ON K1Y 4K4
About Ottawa Allergy Research Corp
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Aimmune Therapeutics, Inc.
5
CSL Behring
3
Shire
3
Celgene
2
Circassia Limited
2
Eli Lilly and Company
2
Hoffmann-La Roche
2
Pharming Technologies B.V.
2
Allergy Therapeutics
1
AnaptysBio, Inc.
1
DBV Technologies
1
Clinical Trials at Ottawa Allergy Research Corp
During the past decade, Ottawa Allergy Research Corp conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 14 clinical trials were completed, i.e. on
average, 77.8% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 7 clinical trials were completed. i.e. 116.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Different Doses of Tyrosine Adsorbed Grass Pollen Allergoid With Monophosphoryl Lipid A (MPL) in Patients Sensitized to Grass Pollen
2005-09-12
2005-11-08
Completed
68
Efficacy, Safety and Immunogenicity Study of Recombinant Human C1 Inhibitor for the Treatment of Acute HAE Attacks
2011-01-01
2013-03-01
Completed
75
A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
2012-07-01
2013-07-01
Completed
301
Study Evaluating the Efficacy and Safety of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate Twice a Day (BID) Using a Novel Bi Directional Device in Subjects With Bilateral Nasal Polyposis Followed by an 8-Week Open-Label Extension Phase to Assess Safety
2013-11-19
2015-10-01
Completed
323
A Study To Assess The Safety And Tolerability Of Different Doses Of PF-06444753 And PF-06444752 In Subjects With Allergic Rhinitis
2012-12-01
2015-06-01
Completed
190
A Study of Lebrikizumab in Participants With Uncontrolled Asthma on Inhaled Corticosteroids and a Second Controller Medication
2013-07-31
2017-01-02
Completed
1,068
Safety Study of Ragweed-SPIRE in Subjects With Ragweed Allergies and Asthma
2014-01-01
2014-10-01
Completed
55
Study of Grass-SPIRE in Subjects With Grass Allergies and Asthma
2014-04-01
2015-03-01
Completed
54
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Ottawa Allergy Research Corp" #1 sponsor was "Aimmune Therapeutics, Inc." with 5 trials, followed by "CSL Behring" with 3 trials
sponsored, "Shire" with 3 trials sponsored, "Celgene" with 2 trials sponsored and "Circassia Limited"
with 2 trials sponsored. Other sponsors include 8 different institutions and
companies that sponsored additional 15 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Ottawa Allergy Research Corp"
#1 collaborator was "Adiga Life Sciences, Inc." with 2 trials as a collaborator, "Dermira, Inc." with 2 trials as a collaborator, "Dyax Corp." with 1 trials as a collaborator, "Ottawa Allergy Research Corporation" with 1 trials as a collaborator and "Takeda Development Center Americas, Inc." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at Ottawa Allergy Research Corp
According to Clinical.Site data, the most researched conditions in "Ottawa Allergy Research Corp" are
"Hereditary Angioedema" (5 trials), "Peanut Allergy" (5 trials), "Asthma" (4 trials), "Atopic Dermatitis" (3 trials) and "Allergic Rhinitis" (2 trials). Many other conditions were trialed in "Ottawa Allergy Research Corp" in a lesser frequency.
Clinical Trials Intervention Types at Ottawa Allergy Research Corp
Most popular intervention types in "Ottawa Allergy Research Corp" are "Biological" (17 trials), "Drug" (13 trials) and "Other" (5 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (15 trials), "AR101" (4 trials), "Lebrikizumab" (3 trials), "CC-93538" (2 trials) and "CSL312" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Ottawa Allergy Research Corp
The vast majority of trials in "Ottawa Allergy Research Corp" are
28 trials for "All" genders.
Clinical Trials Status at Ottawa Allergy Research Corp
Currently, there are NaN active trials in "Ottawa Allergy Research Corp".
undefined are not yet recruiting,
2 are recruiting,
2 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 22 completed trials in Ottawa Allergy Research Corp,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Ottawa Allergy Research Corp, 2 "Phase 1"
clinical trials were conducted, 8 "Phase 2" clinical
trials and 18 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".